Free Trial

Anika Therapeutics (ANIK) Competitors

Anika Therapeutics logo
$11.50 +0.19 (+1.68%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$11.52 +0.02 (+0.13%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ANIK vs. ANVS, CERS, OSUR, UTMD, WST, COO, ALGN, MMSI, HAE, and ICUI

Should you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Annovis Bio (ANVS), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "medical" sector.

Anika Therapeutics vs. Its Competitors

Anika Therapeutics (NASDAQ:ANIK) and Annovis Bio (NYSE:ANVS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 15.8% of Annovis Bio shares are held by institutional investors. 9.6% of Anika Therapeutics shares are held by company insiders. Comparatively, 20.8% of Annovis Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Anika Therapeutics presently has a consensus target price of $20.00, indicating a potential upside of 73.91%. Annovis Bio has a consensus target price of $18.00, indicating a potential upside of 517.50%. Given Annovis Bio's higher probable upside, analysts clearly believe Annovis Bio is more favorable than Anika Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anika Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
Annovis Bio
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

In the previous week, Anika Therapeutics had 1 more articles in the media than Annovis Bio. MarketBeat recorded 2 mentions for Anika Therapeutics and 1 mentions for Annovis Bio. Anika Therapeutics' average media sentiment score of 0.93 beat Annovis Bio's score of 0.92 indicating that Anika Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anika Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Annovis Bio
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Anika Therapeutics has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

Annovis Bio has a net margin of 0.00% compared to Anika Therapeutics' net margin of -41.28%. Anika Therapeutics' return on equity of -7.22% beat Annovis Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Anika Therapeutics-41.28% -7.22% -5.64%
Annovis Bio N/A -300.56%-193.50%

Annovis Bio has lower revenue, but higher earnings than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Annovis Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anika Therapeutics$119.91M1.38-$56.38M-$3.88-2.96
Annovis BioN/AN/A-$24.59M-$2.16-1.35

Summary

Annovis Bio beats Anika Therapeutics on 8 of the 15 factors compared between the two stocks.

Get Anika Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANIK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANIK vs. The Competition

MetricAnika TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$162.20M$3.07B$5.70B$9.50B
Dividend YieldN/A2.37%4.60%4.01%
P/E Ratio-2.9621.1828.1020.05
Price / Sales1.38286.99429.3789.38
Price / Cash118.5742.7636.2258.56
Price / Book1.098.378.665.87
Net Income-$56.38M-$55.19M$3.25B$258.55M
7 Day Performance9.52%5.88%4.22%3.73%
1 Month Performance6.19%17.33%10.51%11.75%
1 Year Performance-58.78%4.42%34.40%18.03%

Anika Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANIK
Anika Therapeutics
4.1409 of 5 stars
$11.50
+1.7%
$20.00
+73.9%
-59.4%$162.20M$119.91M-2.96300Positive News
ANVS
Annovis Bio
1.8523 of 5 stars
$2.87
+5.7%
$18.00
+528.3%
-72.1%$55.84MN/A-1.333
CERS
Cerus
2.8639 of 5 stars
$1.45
flat
$3.50
+141.4%
-41.6%$277.18M$185.14M-14.50290Positive News
Upcoming Earnings
OSUR
OraSure Technologies
2.4364 of 5 stars
$3.07
-1.0%
$3.00
-2.3%
-23.3%$229.64M$185.83M-7.31840Positive News
High Trading Volume
UTMD
Utah Medical Products
1.8854 of 5 stars
$56.69
+0.5%
N/A-16.9%$184.24M$40.90M15.00180News Coverage
Earnings Report
WST
West Pharmaceutical Services
4.4658 of 5 stars
$224.66
-1.1%
$320.00
+42.4%
-5.0%$16.14B$2.89B35.2710,600Trending News
Earnings Report
Dividend Increase
Analyst Forecast
COO
Cooper Companies
3.2947 of 5 stars
$73.61
-1.6%
$99.70
+35.4%
-19.5%$14.72B$3.90B35.7316,000Analyst Upgrade
ALGN
Align Technology
4.6628 of 5 stars
$199.31
-1.5%
$242.92
+21.9%
-9.1%$14.45B$4.00B36.3020,945Positive News
Upcoming Earnings
MMSI
Merit Medical Systems
4.236 of 5 stars
$93.45
0.0%
$109.11
+16.8%
-0.4%$5.52B$1.36B45.817,400Positive News
Upcoming Earnings
HAE
Haemonetics
4.9292 of 5 stars
$76.59
+1.4%
$97.30
+27.0%
-17.0%$3.68B$1.36B23.143,023
ICUI
ICU Medical
4.3627 of 5 stars
$130.85
-1.0%
$192.67
+47.2%
+4.4%$3.22B$2.42B-34.1615,000News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:ANIK) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners